65,437 trials
Infection
Primary: Number of Cough Bouts Over 4-hour Postdose Period — 139.6; 131.3; 126.4 Cough bouts — p=0.216
Breast Cancer
Primary: Overall Survival — 505 Days
Apathy · Alzheimer's Disease
Primary: Apathy — 88.91; 95.64 T-score — p=0.181
Colorectal Cancer
Primary: Progression-free Survival (PFS) — 287; 273 Days — p=0.3883
Liver Transplantation
Primary: Changes in Gastrointestinal Symptom Severity and Health Related Quality of Life — 2.88; 2.10 Scores on a Scale
Healthy Volunteers
Primary: AUC(0-tz) of Unconjugated Rotigotine — 5.2704; 5.4724 ng/ mL*h
Myopia
Primary: Overall Comfort — 3.6685; 3.4352 units on a scale
Upper Respiratory Tract Infection
Primary: Relief of Upper Respiratory Tract Infection (URI) Symptoms (Cough, Runny Nose, Nasal Congestion, Sneezing)1 Hour After Dose of Homeopathic Remedy. — 83; 100; 94; 52 doses
Type 2 Diabetes Mellitus
Primary: Change From Baseline at Day 28 in 24-hour Urinary Glucose Excretion — 35.729; 47.085; -0.965 grams
Degenerative Disc Disease
Primary: Subject Success (Success is Defined Only if All of These Criteria Are Fulfilled) — 0; 0 Subjects
Prostate Cancer
Primary: Probability of Testosterone at Castration Level (≤0.5 ng/mL) From Day 28 Through Day 364 — 89.0; 93.3 percentage of participants
Osteoarthritis · Rheumatoid Arthritis · Post Traumatic Arthritis
Primary: Knee Society Score Evaluation — 82.9 Average Knee Rating Score
Abdominal Obesity
Primary: Change in Visceral Adipose Tissue Area Measured by Computed Tomography. — -1.5; 2.8 cm2
Hypertension
Primary: Change From Baseline in Mean Sitting Systolic Blood Pressure (MSSBP) — 167.0; 168.2; 138.9; 151.6 mm Hg
Refractive Error · Myopia
Primary: Proportion of Eyes Successfully Fit — 0.98; 0.96; 0.96; 0.96 proportion of participant eyes